New combo attack on liver cancer before surgery
Disease control
Recruiting now
This early-stage study is testing whether adding targeted radiation to two immunotherapy drugs is safe and tolerable for people with operable liver cancer. The goal is to shrink tumors before surgery to improve outcomes. About 20 participants will receive either the two drugs alo…
Phase: PHASE1 • Sponsor: Jiping Wang, MD, PhD • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC